Small 'titanide' cells identified as dominant Cryptococcus lung form

Overview

Updated Oct 13

An October 12 paper in PLOS Biology shows that the small end of Cryptococcus neoformans cell sizes matters as much as the giant titan cells that have defined its virulence for a decade. The fungus kills an estimated 180,000 people a year, most of them AIDS patients in sub-Saharan Africa.

Live imaging traced the 2-4 µm ovals, which the authors call titanides, to ordinary yeast mothers averaging 4.9 µm. They turned up in 74 of 81 clinical and environmental isolates and resisted some cell-wall and membrane stressors. In mice they caused disease indistinguishable from typical yeast, though symptoms appeared later, and they were more sensitive than yeast to amphotericin B, a key treatment for severe fungal infections.

Why it matters

Titanides dominate the lung and withstand some stresses but not amphotericin B, so treatment and vaccine design may need to account for them.

Questions about this story

Free account needed to ask — your question is kept and asked for you right after sign-up. Answers are public.

No questions yet — be the first to ask.

Key Indicators

4-10%

Titanide share of cells at 24 hours

Titanides appear within a day of host-relevant conditions and grow to dominate by 72 hours.

2-4 µm

Titanide cell size

Small oval cells, distinct from typical 5-7 µm yeast and >10 µm titan cells.

72 h

Time to titanide dominance

By 72 hours post-induction, titanides are the dominant morphotype in culture.

74/81

Isolates producing titanides

Titanides appeared in 74 of 81 clinical and environmental isolates, making the trait near-universal.

More sensitive

Response to amphotericin B

Titanides were more sensitive than typical yeast to amphotericin B, a key treatment for severe fungal infections.

Voices

Curated perspectives — historical figures and your fellow readers.

People Involved

Elizabeth R. Ballou

Corresponding author, fungal geneticist

Led the titanide characterization study

Abigail M. Potton

First author, researcher

Led the experimental work on titanide biology

Gordon D. Brown

Co-author, immunologist

Contributed immunology expertise to the study

Organizations Involved

PLOS Biology

Peer-reviewed scientific journal

Published the titanide characterization study

Open-access journal that published the first full characterization of the titanide morphotype.

University of Exeter

Research university

Host institution for the titanide research team

UK university whose fungal pathogenesis lab produced the titanide study.

Timeline

2015 October 2026

4 events Latest: October 12th, 2026 · 1 month ago

Tap a bar to jump to that date

October 2026
Titanides characterized as distinct pathogenic morphotype
Latest Research

PLOS Biology paper defines titanides as 2-4 µm oval cells that dominate lung infection and resist antifungal stress.
October 12th, 2026
March 2021
Reactive nitrogen species shown to trigger yeast-to-titan switch
Research

bioRxiv preprint demonstrates host immune signals drive titanization via endogenous superoxide accumulation.
March 1st, 2021
2018
In vitro titan cell model developed
Research

Researchers create a standardized assay for yeast-to-titan transition, enabling genetic and environmental studies.
2018
2015
Polyploid titan cells shown to produce haploid and aneuploid progeny
Research

mBio study shows titan cells generate stress-adapted progeny, establishing titanization as a virulence mechanism.
2015

Scenarios

Titanides confirmed as key to brain invasion

Possible Resolves by Oct 12, 2027

Discussed by: The paper's authors, who note titanides are effective infectious propagules in murine models

Follow-up studies test whether titanides cross the blood-brain barrier more efficiently than typical yeast cells. If confirmed, titanides would become a primary target for drugs aimed at preventing cryptococcal meningitis, the deadliest manifestation of infection.

Titanide formation becomes antifungal drug target

Possible Resolves by Oct 12, 2028

Discussed by: The paper's finding that titanides resist cell wall and membrane stressors

Researchers screen for compounds that block the yeast-to-titanide transition. A successful hit would reduce fungal burden and drug tolerance in animal models, opening a new class of antifungal therapies that target morphogenesis rather than growth.

Titanide classification challenged as continuum artifact

Possible Resolves by Oct 12, 2027

Discussed by: The field's history of overlapping small-cell descriptions (seed cells, micro cells, ovoid cells)

Other groups argue titanides are part of a morphological continuum rather than a discrete cell type, citing the PLOS Pathogens ovoid cell study that described a similar small morphotype with different properties. A nomenclature debate could slow clinical translation.

Titanides Persist as a Latent Lung Reservoir

Possible Resolves by End of 2027

Discussed by: The paper's live-imaging and growth-arrest observations

Newborn titanides stop proliferating, then revive in fresh medium. That arrest-and-resume pattern is the signature of a latent cell, and C. neoformans infection can sit in the lung for years. Whether titanides are the cells that reactivate when a person later becomes immunocompromised is still unresolved.

Amphotericin B sensitivity changes how titanide infections are treated

Possible Resolves by Oct 31, 2027

Discussed by: The University of Exeter team's October 23 summary of the paper's findings

Titanides were more sensitive to amphotericin B than typical yeast in the lab. Whether that holds during lung infection, and whether titanides survive treatment as a reservoir, is untested. A confirmed difference would give clinicians a reason to check which morphotypes dominate a patient's infection.

Historical Context

3 moments from history that rhyme with this story — and how they unfolded.

2010-2018

Titan cell discovery (2010-2018)

Researchers found that Cryptococcus neoformans produces giant polyploid cells (>10 µm, up to 100 µm) in the lung. These titan cells resist phagocytosis, survive oxidative stress, and produce haploid or aneuploid progeny that adapt to host conditions.

Then

Titan cells were established as a major virulence factor, and in vitro models were developed to study the yeast-to-titan transition.

Now

The titan cell paradigm shaped a decade of research on cryptococcal morphogenesis and host-pathogen interaction.

Why this matters now

The titanide discovery extends the same morphogenesis framework to the small end of the size spectrum, showing that both extremes of cell size drive virulence.

1990s-2000s

Candida albicans yeast-to-hyphae switch (1990s-2000s)

Candida albicans, the most common human fungal pathogen, switches between yeast and hyphal forms. Researchers showed this morphogenesis is required for tissue invasion and virulence, making it a central target for antifungal drug development.

Then

Morphogenesis became a recognized virulence determinant in medical mycology.

Now

The yeast-to-hyphae switch remains a model for how fungal cell shape drives disease outcome.

Why this matters now

The titanide work applies the same logic — cell shape and size determine virulence — to Cryptococcus, a pathogen that was thought to lack morphogenetic complexity.

2010s

Cryptococcus seed cell discovery (2010s)

Researchers identified 'seed cells,' 4-6 µm cells with high cell-wall mannan content that are thought to seed central nervous system infection. These small cells were the first evidence that Cryptococcus uses small morphotypes for dissemination.

Then

Seed cells were proposed as the infectious propagules that cross the blood-brain barrier.

Now

The seed cell concept opened the door to studying small-cell morphotypes as virulence determinants.

Why this matters now

Titanides are now distinguished from seed cells by their thinner cell walls and reduced pathogen-associated molecular pattern exposure, refining the map of small-cell types.